Overexpression of Cell Cycle Proteins of Peripheral Lymphocytes in Patients with Alzheimer’s Disease
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
ObjectiveaaBiological markers for Alzheimer’s disease (AD) will help clinicians make objective diagnoses early during the course of dementia. Previous studies have suggested that cell cycle dysregulation begins earlier than the onset of clinical manifestations in AD. MethodsaaWe examined the lymphocyte expression of cell cycle proteins in AD patients, dementia controls (DC), and normal controls (NC). One-hundred seventeen subjects (36 AD, 31 DC, and 50 NC) were recruited. The cell cycle proteins CDK2, CDK4, CDK6, cyclin B, and cyclin D were measured in peripheral lymphocytes. Cell cycle protein expression in the three groups was compared after adjusting for age and sex. ResultsaaThe levels of cell cycle proteins CDK2, CDK4, CDK6, cyclin B, and cyclin D were significantly higher in AD patients than in the NC subjects. The DC group manifested intermediate levels of cell cycle proteins compared with the AD patients and the NC subjects. The present study indicates that cell cycle proteins are upregulated in the peripheral lymphocytes of AD patients. ConclusionaaCell cycle dysregulation in peripheral lymphocytes may present a promising starting point for identifying peripheral biomarkers of AD.
Abstract
ObjectiveaaBiological markers for Alzheimer’s disease (AD) will help clinicians make objective diagnoses early during the course of dementia. Previous studies have suggested that cell cycle dysregulation begins earlier than the onset of clinical manifestations in AD. MethodsaaWe examined the lymphocyte expression of cell cycle proteins in AD patients, dementia controls (DC), and normal controls (NC). One-hundred seventeen subjects (36 AD, 31 DC, and 50 NC) were recruited. The cell cycle proteins CDK2, CDK4, CDK6, cyclin B, and cyclin D were measured in peripheral lymphocytes. Cell cycle protein expression in the three groups was compared after adjusting for age and sex. ResultsaaThe levels of cell cycle proteins CDK2, CDK4, CDK6, cyclin B, and cyclin D were significantly higher in AD patients than in the NC subjects. The DC group manifested intermediate levels of cell cycle proteins compared with the AD patients and the NC subjects. The present study indicates that cell cycle proteins are upregulated in the peripheral lymphocytes of AD patients. ConclusionaaCell cycle dysregulation in peripheral lymphocytes may present a promising starting point for identifying peripheral biomarkers of AD.
참고문헌 (41)
- Busser J, "Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer’s disease brain", J Neurosci, 18, pp.2801~2807 (1998)
- McShea A, "Neuronal cell cycle re-entry mediates Alzheimer disease-type changes", Biochim Biophys Acta, 1772, pp.467~472 (2007)
- Nuydens R, "Okadaic acid-induced apoptosis in neuronal cells : evidence for an abortive mitotic attempt", J Neurochem, 70, pp.1124~1133 (1998)
- Raina AK, "Cyclin’ toward dementia : cell cycle abnormalities and abortive oncogenesis in Alzheimer disease", J Neurosci Res, 61, pp.128~133 (2000)
- Vincent I, "Aberrant expression of mitotic cdc2", cyclin B1 kinase in degenerating neurons of Alzheimer’s disease brain, 1997, pp.17, 3588~3598
- Yang Y, "Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease", J Neurosci, 23, pp.2557~2563 (2003)
- Arendt T, "Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer’s disease", Neuroreport, 7, pp.3047~3049 (1996)
- Kondratick CM, "Alzheimer’s disease neurofibrillary tangles contain mitosis-specific phosphoepitopes", J Neurochem, 67, pp.2405~2416 (1996)
- Hoozemans JJ, "Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2(COX-2)in pyramidal neurons in Alzheimer disease temporal cortex", J Neuropathol Exp Neurol, 61, pp.678~688 (2002)
- Nagy Z, "Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer’s disease", Neurosci Lett, 317, pp.81~84 (2002)
- Sultana R, "Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer’s disease : insights into the role of oxidative stress in Alzheimer’s disease and initial investigations into a potential biomarker for this dementing disorder", J Alzheimers Dis, 24, pp.77~84 (2011)
- Leuner K, "Peripheral mitochondrial dysfunction in Alzheimer’s disease : focus on lymphocytes", Mol Neurobiol, 46, pp.194~204 (2012)
- Behrens MI, "Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer’s patients and skin cancer survivors : increased apoptosis in Alzheimer’s and reduced necrosis in cancer", J Gerontol A Biol Sci Med Sci, 67, pp.1036~1040 (2012)
- Urcelay E, "Enhanced proliferation of lymphoblasts from patients with Alzheimer dementia associated with calmodulin-dependent activation of the na+", H+ exchanger, 2001, pp.8, 289~298
- 윤세창, "Altered Cell Viability and Proliferation Activity of Peripheral Lymphocytes in Patients with Alzheimer’s Disease", PSYCHIATRY INVESTIGATION, 7(1), pp.68~71 (2010), 대한신경정신의학회
- Erkinjuntti T, "Research criteria for subcortical vascular dementia in clinical trials", J Neural Transm Suppl, 59, pp.23~30 (2000)
- Kang Y, "A validity study on the Korean Mini-Mental Status Examination(K-MMSE)in dementia patients", J Korean Neurol Assoc, 15, pp.300~308 (1997)
- 구형모, "일상활동평가-복합(Seoul-Instrumental Activities of Daily Living ; S-IADL)의 신뢰도 및 타당도 연구", 신경정신의학, 43(2), pp.189~199 (2004), 대한신경정신의학회
- Morris JC, "The Clinical Dementia Rating(CDR) : current version and scoring rules", Neurology, 43, pp.2412~2414 (1993)
- Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
- Rusk R, "Comparison of the utility of two abbreviated forms of the MMPI for psychiatric screening of the elderly", J Clin Psychol, 35, pp.104~107 (1979)
- Arbogast A, "Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein", Cell Immunol, 197, pp.46~54 (1999)
- Boonstra J, "Progression through the G1-phase of the on-going cell cycle", J Cell Biochem, 90, pp.244~252 (2003)
- Sanchez I, "New insights into cyclins, CDKs, and cell cycle control", Semin Cell Dev Biol, 16, pp.311~321 (2005)
- Coqueret O, "Linking cyclins to transcriptional control", Gene, 299, pp.35~55 (2002)
- Giovanni A, "Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death", J Biol Chem, 274, pp.19011~19016 (1999)
- Arellano M, "Regulation of CDK", cyclin complexes during the cell cycle, 1997, pp.29, 559~573
- Morgan DO, "Principles of CDK regulation", Nature, 374, pp.131~134 (1995)
- Felten DL, "Noradrenergic sympathetic neural interactions with the immune system : structure and function", Immunol Rev, 100, pp.225~260 (1987)
- Gladkevich A, "Lymphocytes as a neural probe : potential for studying psychiatric disorders", Prog Neuropsychopharmacol Biol Psychiatry, 28, pp.559~576 (2004)
- Kadioglu E, "Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer’s disease", Biomarkers, 9, pp.203~209 (2004)
- Mecocci P, "Oxidative damage to DNA in lymphocytes from AD patients", Neurology, 51, pp.1014~1017 (1998)
- Sulger J, "The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer’s dementia", Biol Psychiatry, 45, pp.737~742 (1999)
- Tacconi S, "Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer’s disease", Exp Neurol, 190, pp.254~262 (2004)
- peptide and iron promote apoptosis in lymphocytes by an oxidative stress mech anism: involvement of H2O2, caspase-3, NF-kappaB, p53 and c-Jun, "Neurotoxicology", 2002, 351~365
- de las Cuevas N, "Ca2+", calmodulin-dependent modulation of cell cycle elements pRb and p27kip1 involved in the enhanced proliferation of lymphoblasts from patients with Alzheimer dementia, 2003, pp.13, 254~263
- Munoz U, "Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1)in immortalized lymphocytes from Alzheimer’s dementia patients", Neurobiol Aging, 29, pp.1474~1484 (2008)
- Zana M, "Alzheimer’s lymphocytes are resistant to ultraviolet B-induced apoptosis", Neurobiol Aging, 27, pp.831~834 (2006)
- Husseman JW, "Mitotic activation : a convergent mechanism for a cohort of neurodegenerative diseases", Neurobiol Aging, 21, pp.815~828 (2000)
- Timsit S, "Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death?", Eur J Neurosci, 11, pp.263~278 (1999)
- van Lookeren Campagne M, "Increased expression of cyclin G1 and p21WAF1", CIP1 in neurons following transient forebrain ischemia : comparison with early DNA damage, 1998, pp.53, 279~296